appropriate serologic testing to evaluate rheumatic …do not treat asymptomatic hyperuricemia –...
TRANSCRIPT
![Page 1: Appropriate Serologic Testing to Evaluate Rheumatic …Do not treat asymptomatic hyperuricemia – 43 million have hyperuricemia , 8 million with gout During gout flare, urate can](https://reader033.vdocuments.site/reader033/viewer/2022060410/5f105d1a7e708231d448be0c/html5/thumbnails/1.jpg)
Appropriate Serologic Testing Appropriate Serologic Testing
to Evaluate Rheumatic to Evaluate Rheumatic
ComplaintsComplaints
Kathleen M Thomas DOKathleen M Thomas DOCommunity RheumatologyCommunity Rheumatology
Community Physician NetworkCommunity Physician Network
Noblesville, IndianaNoblesville, Indiana
April 26, 2012April 26, 2012
![Page 2: Appropriate Serologic Testing to Evaluate Rheumatic …Do not treat asymptomatic hyperuricemia – 43 million have hyperuricemia , 8 million with gout During gout flare, urate can](https://reader033.vdocuments.site/reader033/viewer/2022060410/5f105d1a7e708231d448be0c/html5/thumbnails/2.jpg)
Objectives Objectives
�� Describe lab tests most useful in the Describe lab tests most useful in the evaluation of common rheumatic diseasesevaluation of common rheumatic diseases
�� Recognize the serologic associations of Recognize the serologic associations of rheumatic diseasesrheumatic diseases
�� Apply sensitivity, specificity, likelihood Apply sensitivity, specificity, likelihood ratio (LR) and positive predictive value to ratio (LR) and positive predictive value to laboratory testing in clinical practicelaboratory testing in clinical practice
![Page 3: Appropriate Serologic Testing to Evaluate Rheumatic …Do not treat asymptomatic hyperuricemia – 43 million have hyperuricemia , 8 million with gout During gout flare, urate can](https://reader033.vdocuments.site/reader033/viewer/2022060410/5f105d1a7e708231d448be0c/html5/thumbnails/3.jpg)
Case study #1Case study #1
�� 28 28 yy--oo female with 6 months of female with 6 months of HAsHAs, , fatigue and fatigue and arthralgiasarthralgias. She hurts all . She hurts all day, Advil, Tylenol provide no relief. day, Advil, Tylenol provide no relief. Occasional oral ulcers around Occasional oral ulcers around menses. Going through divorce and menses. Going through divorce and worried about her kidsworried about her kids
��On exam muscle and joints, including On exam muscle and joints, including hands and feet, are tender, she is hands and feet, are tender, she is weepyweepy
![Page 4: Appropriate Serologic Testing to Evaluate Rheumatic …Do not treat asymptomatic hyperuricemia – 43 million have hyperuricemia , 8 million with gout During gout flare, urate can](https://reader033.vdocuments.site/reader033/viewer/2022060410/5f105d1a7e708231d448be0c/html5/thumbnails/4.jpg)
Case study #1Case study #1
�� What do you suspect?What do you suspect?–– LupusLupus
–– RARA
–– FibromyalgiaFibromyalgia
–– Depression/anxietyDepression/anxiety
�� What would you order?What would you order?–– ANA, RF, ESR, uric acidANA, RF, ESR, uric acid
–– Sleep studySleep study
–– Vitamin D, TSH, hepatitis panel, CKVitamin D, TSH, hepatitis panel, CK
![Page 5: Appropriate Serologic Testing to Evaluate Rheumatic …Do not treat asymptomatic hyperuricemia – 43 million have hyperuricemia , 8 million with gout During gout flare, urate can](https://reader033.vdocuments.site/reader033/viewer/2022060410/5f105d1a7e708231d448be0c/html5/thumbnails/5.jpg)
Objective 1Objective 1
��Describe lab tests most useful in the Describe lab tests most useful in the
evaluation of common rheumatic evaluation of common rheumatic
diseasesdiseases
![Page 6: Appropriate Serologic Testing to Evaluate Rheumatic …Do not treat asymptomatic hyperuricemia – 43 million have hyperuricemia , 8 million with gout During gout flare, urate can](https://reader033.vdocuments.site/reader033/viewer/2022060410/5f105d1a7e708231d448be0c/html5/thumbnails/6.jpg)
Initial Approach When Faced with Diffuse Initial Approach When Faced with Diffuse
Rheumatic Disease PresentationRheumatic Disease Presentation
�� Is it arthritis (in the joints) or not Is it arthritis (in the joints) or not (bursitis, fibromyalgia, etc)(bursitis, fibromyalgia, etc)–– Answer by H&PAnswer by H&P
�� Is it inflammatory or not?Is it inflammatory or not?–– Answer by H&PAnswer by H&P
–– Labs: ESR, CRP, CBCLabs: ESR, CRP, CBC
�� If arthritis, is it one of the common If arthritis, is it one of the common inflammatory conditions?inflammatory conditions?–– Answer by H&PAnswer by H&P
–– Labs: RF, CCP, ANA panelLabs: RF, CCP, ANA panel
![Page 7: Appropriate Serologic Testing to Evaluate Rheumatic …Do not treat asymptomatic hyperuricemia – 43 million have hyperuricemia , 8 million with gout During gout flare, urate can](https://reader033.vdocuments.site/reader033/viewer/2022060410/5f105d1a7e708231d448be0c/html5/thumbnails/7.jpg)
Diagnostic Laboratory Evaluation of Diagnostic Laboratory Evaluation of
Possible Inflammatory ArthritisPossible Inflammatory Arthritis
�� Inflammatory markersInflammatory markers
–– ESR and/or CRPESR and/or CRP
�� For diagnosis/prognosis: RF and CCPFor diagnosis/prognosis: RF and CCP
��Consider ANA panelConsider ANA panel
–– Patients may be Patients may be seronegativeseronegative early in early in
disease, and even have normal disease, and even have normal
ESR/CRP, but a +ANA may heighten ESR/CRP, but a +ANA may heighten
suspicionsuspicion
![Page 8: Appropriate Serologic Testing to Evaluate Rheumatic …Do not treat asymptomatic hyperuricemia – 43 million have hyperuricemia , 8 million with gout During gout flare, urate can](https://reader033.vdocuments.site/reader033/viewer/2022060410/5f105d1a7e708231d448be0c/html5/thumbnails/8.jpg)
Rheumatoid FactorRheumatoid Factor
�� RF is an autoantibody directed against RF is an autoantibody directed against IgGIgG
![Page 9: Appropriate Serologic Testing to Evaluate Rheumatic …Do not treat asymptomatic hyperuricemia – 43 million have hyperuricemia , 8 million with gout During gout flare, urate can](https://reader033.vdocuments.site/reader033/viewer/2022060410/5f105d1a7e708231d448be0c/html5/thumbnails/9.jpg)
Rheumatoid FactorRheumatoid Factor
�� Present in 70Present in 70--80% of RA patients 80% of RA patients vsvs
about 5% of normal populationabout 5% of normal population
��Also present in other rheumatic Also present in other rheumatic
diseases and chronic diseasediseases and chronic disease
�� Prognostic value: Prognostic value: high levels high levels
associated with more severe joint associated with more severe joint
disease and extradisease and extra--articulararticular diseasedisease
![Page 10: Appropriate Serologic Testing to Evaluate Rheumatic …Do not treat asymptomatic hyperuricemia – 43 million have hyperuricemia , 8 million with gout During gout flare, urate can](https://reader033.vdocuments.site/reader033/viewer/2022060410/5f105d1a7e708231d448be0c/html5/thumbnails/10.jpg)
Rheumatoid FactorRheumatoid Factor
�� Assists in diagnosisAssists in diagnosis
–– In a patient with suggestive findings In a patient with suggestive findings
(symmetric (symmetric polyarthritispolyarthritis), presence increases ), presence increases
the certainty of diagnosis, if other causes the certainty of diagnosis, if other causes
excludedexcluded
�� Assists in prognosisAssists in prognosis
–– High titer increases the progression to erosive High titer increases the progression to erosive
arthritisarthritis
�� Assists in treatment decisionsAssists in treatment decisions
–– Warrants early DMARD useWarrants early DMARD use
![Page 11: Appropriate Serologic Testing to Evaluate Rheumatic …Do not treat asymptomatic hyperuricemia – 43 million have hyperuricemia , 8 million with gout During gout flare, urate can](https://reader033.vdocuments.site/reader033/viewer/2022060410/5f105d1a7e708231d448be0c/html5/thumbnails/11.jpg)
Clinical associations of RFClinical associations of RF
�� Rheumatoid arthritis (75Rheumatoid arthritis (75--80%)80%)
�� Other rheumatic diseaseOther rheumatic disease–– SjogrenSjogren’’ss syndrome (~90%)syndrome (~90%)
–– SLE (15SLE (15--20%)20%)
–– SarcoidosisSarcoidosis (~15%)(~15%)
–– Parvovirus Parvovirus arthropathyarthropathy (~15%, transient)(~15%, transient)
–– Mixed Mixed cryoglobulinemiacryoglobulinemia (95%)(95%)
�� Chronic infectionsChronic infections–– Chronic Chronic HepHep CC
–– OsteomyelitisOsteomyelitis
–– Bacterial Bacterial endocarditisendocarditis
�� Monoclonal Monoclonal IgMIgM paraproteinsparaproteins
�� Normal aging (present at low titer)Normal aging (present at low titer)
![Page 12: Appropriate Serologic Testing to Evaluate Rheumatic …Do not treat asymptomatic hyperuricemia – 43 million have hyperuricemia , 8 million with gout During gout flare, urate can](https://reader033.vdocuments.site/reader033/viewer/2022060410/5f105d1a7e708231d448be0c/html5/thumbnails/12.jpg)
Frequency of +RF in Normal PopulationFrequency of +RF in Normal Population
by Ageby Age
1010--25%25%>70 yrs>70 yrs
5%5%6060--70 yrs70 yrs
22--4%4%2020--60 yrs60 yrs
Frequency of Frequency of
+RF+RF
AGEAGE
![Page 13: Appropriate Serologic Testing to Evaluate Rheumatic …Do not treat asymptomatic hyperuricemia – 43 million have hyperuricemia , 8 million with gout During gout flare, urate can](https://reader033.vdocuments.site/reader033/viewer/2022060410/5f105d1a7e708231d448be0c/html5/thumbnails/13.jpg)
RF as RF as ““screeningscreening””
�� RARA–– Prevalence of RA ~1.2% in USPrevalence of RA ~1.2% in US
–– +RF 80%+RF 80%
�� HCVHCV–– Prevalence ~1Prevalence ~1--2% in US2% in US
–– RF+ rate 40RF+ rate 40--70%70%
�� Given positive RF in US population, risk of Given positive RF in US population, risk of HCV about the same as RAHCV about the same as RA
�� Consider HCV arthritis in RF+ patient with Consider HCV arthritis in RF+ patient with nonnon--erosive disease or erosive disease or arthralgiasarthralgias
![Page 14: Appropriate Serologic Testing to Evaluate Rheumatic …Do not treat asymptomatic hyperuricemia – 43 million have hyperuricemia , 8 million with gout During gout flare, urate can](https://reader033.vdocuments.site/reader033/viewer/2022060410/5f105d1a7e708231d448be0c/html5/thumbnails/14.jpg)
Cyclic Cyclic CitrullinatedCitrullinated Peptide Peptide
antibodyantibody
��Also called Also called ACPAsACPAs
��CitrullinationCitrullination is a postis a post--translational translational
modification of modification of argininearginine
�� Peptides after Peptides after citrullinationcitrullination have have
increased affinity for MHCII binding increased affinity for MHCII binding
groove of HLA DRB1 0401 allelegroove of HLA DRB1 0401 allele
��AntiAnti--CCP antibodies locally produced CCP antibodies locally produced
by plasma cells in by plasma cells in synoviumsynovium
![Page 15: Appropriate Serologic Testing to Evaluate Rheumatic …Do not treat asymptomatic hyperuricemia – 43 million have hyperuricemia , 8 million with gout During gout flare, urate can](https://reader033.vdocuments.site/reader033/viewer/2022060410/5f105d1a7e708231d448be0c/html5/thumbnails/15.jpg)
Cyclic Cyclic CitrullinatedCitrullinated Peptide antibodyPeptide antibody
��Similar sensitivity as RF, Similar sensitivity as RF, greatergreater
specificityspecificity
–– Less common with Less common with SjogrensSjogrens or SLEor SLE
––Not seen in HCV or other chronic Not seen in HCV or other chronic
infections or PMRinfections or PMR
��Often present Often present earlyearly, and predictive of , and predictive of
severe, erosive diseasesevere, erosive disease
��Can be discordant with RFCan be discordant with RF
![Page 16: Appropriate Serologic Testing to Evaluate Rheumatic …Do not treat asymptomatic hyperuricemia – 43 million have hyperuricemia , 8 million with gout During gout flare, urate can](https://reader033.vdocuments.site/reader033/viewer/2022060410/5f105d1a7e708231d448be0c/html5/thumbnails/16.jpg)
RF and CCPRF and CCP
78%78%74%74%RFRF
97%97%77%77%AntiAnti--CCPCCP
SpecificitySpecificitySensitivitySensitivity
![Page 17: Appropriate Serologic Testing to Evaluate Rheumatic …Do not treat asymptomatic hyperuricemia – 43 million have hyperuricemia , 8 million with gout During gout flare, urate can](https://reader033.vdocuments.site/reader033/viewer/2022060410/5f105d1a7e708231d448be0c/html5/thumbnails/17.jpg)
2010 Classification Criteria2010 Classification Criteria
�� More emphasis on clinical presentation, shift More emphasis on clinical presentation, shift
away from older criteria like nodules and away from older criteria like nodules and
radiographic damageradiographic damage
![Page 18: Appropriate Serologic Testing to Evaluate Rheumatic …Do not treat asymptomatic hyperuricemia – 43 million have hyperuricemia , 8 million with gout During gout flare, urate can](https://reader033.vdocuments.site/reader033/viewer/2022060410/5f105d1a7e708231d448be0c/html5/thumbnails/18.jpg)
2010 ACR/EULAR
Classification Criteria for RAJOINT DISTRIBUTION (0JOINT DISTRIBUTION (0--5)5)
1 large joint1 large joint 00
22--10 large joints 10 large joints 11
11--3 small joints (large joints not counted)3 small joints (large joints not counted) 22
44--10 small joints (large joints not counted)10 small joints (large joints not counted) 33
>10 joints (at least one small joint)>10 joints (at least one small joint) 55
SEROLOGY (0SEROLOGY (0--3)3)
Negative RF Negative RF ANDAND negative ACPAnegative ACPA 00
Low positive RF Low positive RF OROR low positive ACPAlow positive ACPA 22
High positive RF High positive RF OROR high positive ACPAhigh positive ACPA 33
SYMPTOM DURATION (0SYMPTOM DURATION (0--1)1)
<6 weeks<6 weeks 00
≥≥6 weeks6 weeks 11
ACUTE PHASE REACTANTS (0ACUTE PHASE REACTANTS (0--1)1)
Normal CRP Normal CRP ANDAND normal ESRnormal ESR 00
Abnormal CRP Abnormal CRP OROR abnormal ESRabnormal ESR 11
≥6 = definite RA
What if the score is <6?
Patient might fulfill the criteria…
� Prospectively over time
(cumulatively)
���� Retrospectively if data on all
four domains have been
adequately recorded in the past
![Page 19: Appropriate Serologic Testing to Evaluate Rheumatic …Do not treat asymptomatic hyperuricemia – 43 million have hyperuricemia , 8 million with gout During gout flare, urate can](https://reader033.vdocuments.site/reader033/viewer/2022060410/5f105d1a7e708231d448be0c/html5/thumbnails/19.jpg)
Acute Phase ProteinsAcute Phase Proteins
�� Proteins whose plasma Proteins whose plasma concentrations change by at least concentrations change by at least 25% during inflammatory states25% during inflammatory states
�� Those that increase are called Those that increase are called positive phase reactants, e.g. CRP, positive phase reactants, e.g. CRP, haptoglobinhaptoglobin, , ferritinferritin
��Negative reactants decrease with Negative reactants decrease with inflammation, e.g. albumin, inflammation, e.g. albumin, transferrintransferrin
![Page 20: Appropriate Serologic Testing to Evaluate Rheumatic …Do not treat asymptomatic hyperuricemia – 43 million have hyperuricemia , 8 million with gout During gout flare, urate can](https://reader033.vdocuments.site/reader033/viewer/2022060410/5f105d1a7e708231d448be0c/html5/thumbnails/20.jpg)
Acute Phase ReactantsAcute Phase Reactants
�� Lack specificity, but can be useful in Lack specificity, but can be useful in
reflecting the presence and intensity reflecting the presence and intensity
of inflammatory processof inflammatory process
��Most commonly used ESR and CRPMost commonly used ESR and CRP
![Page 21: Appropriate Serologic Testing to Evaluate Rheumatic …Do not treat asymptomatic hyperuricemia – 43 million have hyperuricemia , 8 million with gout During gout flare, urate can](https://reader033.vdocuments.site/reader033/viewer/2022060410/5f105d1a7e708231d448be0c/html5/thumbnails/21.jpg)
Case # 2Case # 2
�� 76 76 yoyo female awoke with stiffness in her female awoke with stiffness in her neck and shoulders, trouble climbing out neck and shoulders, trouble climbing out of bed; persisted for weeksof bed; persisted for weeks
�� Fatigue, anorexia, pain awakens her at Fatigue, anorexia, pain awakens her at night, feels weak, no swollen joints or night, feels weak, no swollen joints or vision changesvision changes
�� One exam, normal temporal arteries, no One exam, normal temporal arteries, no scalp tenderness. She moves slowly, scalp tenderness. She moves slowly, temp 100.1, givetemp 100.1, give--way weakness of way weakness of proximal muscles due to painproximal muscles due to pain
�� ESR 92 = ESR 92 = PMRPMR
![Page 22: Appropriate Serologic Testing to Evaluate Rheumatic …Do not treat asymptomatic hyperuricemia – 43 million have hyperuricemia , 8 million with gout During gout flare, urate can](https://reader033.vdocuments.site/reader033/viewer/2022060410/5f105d1a7e708231d448be0c/html5/thumbnails/22.jpg)
ESRESR
��A measure of the distance in A measure of the distance in millimeters that millimeters that RBCsRBCs fall in a tube fall in a tube over an hourover an hour
��An An indirectindirect measurement of measurement of alterations in acutealterations in acute--phase reactantsphase reactants
��Results can be affected by anemiaResults can be affected by anemia
��Changes slowly with change in Changes slowly with change in conditioncondition
��Normal values higher for womenNormal values higher for women
![Page 23: Appropriate Serologic Testing to Evaluate Rheumatic …Do not treat asymptomatic hyperuricemia – 43 million have hyperuricemia , 8 million with gout During gout flare, urate can](https://reader033.vdocuments.site/reader033/viewer/2022060410/5f105d1a7e708231d448be0c/html5/thumbnails/23.jpg)
ESRESR
��Markedly elevated (>100mm/hr)Markedly elevated (>100mm/hr)–– InfectionInfection
––MalignancyMalignancy
–– VasculitisVasculitis (CTD(CTD--related, GCA)related, GCA)
��Markedly lowMarkedly low–– AfibrinogenemiaAfibrinogenemia
–– AgammaglobulinemiaAgammaglobulinemia
–– Extreme Extreme polycythemiapolycythemia ((HctHct>65%)>65%)
–– Increased plasma Increased plasma vicosityvicosity
![Page 24: Appropriate Serologic Testing to Evaluate Rheumatic …Do not treat asymptomatic hyperuricemia – 43 million have hyperuricemia , 8 million with gout During gout flare, urate can](https://reader033.vdocuments.site/reader033/viewer/2022060410/5f105d1a7e708231d448be0c/html5/thumbnails/24.jpg)
ESRESR
�� It has been suggested that patients It has been suggested that patients
with PMR presenting with lower ESR with PMR presenting with lower ESR
may require lower doses of steroids may require lower doses of steroids
and shorter duration of treatmentand shorter duration of treatment
�� Patients with GCA and lower ESR at Patients with GCA and lower ESR at
higher risk for visual complicationshigher risk for visual complications
![Page 25: Appropriate Serologic Testing to Evaluate Rheumatic …Do not treat asymptomatic hyperuricemia – 43 million have hyperuricemia , 8 million with gout During gout flare, urate can](https://reader033.vdocuments.site/reader033/viewer/2022060410/5f105d1a7e708231d448be0c/html5/thumbnails/25.jpg)
CRPCRP
��AcuteAcute--phase reactant produced in phase reactant produced in
response to ILresponse to IL--6 and other cytokines6 and other cytokines
�� Elevation occurs within 4 hours of Elevation occurs within 4 hours of
injury and peaks in 24injury and peaks in 24--72 hours72 hours
��Able to activate the classic Able to activate the classic
complement cascadecomplement cascade
![Page 26: Appropriate Serologic Testing to Evaluate Rheumatic …Do not treat asymptomatic hyperuricemia – 43 million have hyperuricemia , 8 million with gout During gout flare, urate can](https://reader033.vdocuments.site/reader033/viewer/2022060410/5f105d1a7e708231d448be0c/html5/thumbnails/26.jpg)
ESR ESR vsvs CRPCRP
�� CRPCRP
–– Better correlates with RA and Better correlates with RA and seronegativeseronegative
spondyloarthritisspondyloarthritis disease activitydisease activity
�� ESRESR
–– Better correlates with SLE activityBetter correlates with SLE activity
�� Discrepancies found with some frequencyDiscrepancies found with some frequency
–– Probably due to differences in production of Probably due to differences in production of
specific cytokines or their modulators in specific cytokines or their modulators in
different diseasesdifferent diseases
![Page 27: Appropriate Serologic Testing to Evaluate Rheumatic …Do not treat asymptomatic hyperuricemia – 43 million have hyperuricemia , 8 million with gout During gout flare, urate can](https://reader033.vdocuments.site/reader033/viewer/2022060410/5f105d1a7e708231d448be0c/html5/thumbnails/27.jpg)
ESR and CRPESR and CRP
�� Measurement of any acute phase reactant Measurement of any acute phase reactant
must take into account how the results must take into account how the results
will affect management will affect management
–– H&P generally more reliable reflection of H&P generally more reliable reflection of
disease activitydisease activity
�� Knowing which acute phase reactant Knowing which acute phase reactant
historically correlates with the patienthistorically correlates with the patient’’s s
disease helps chose which to follow over disease helps chose which to follow over
timetime
![Page 28: Appropriate Serologic Testing to Evaluate Rheumatic …Do not treat asymptomatic hyperuricemia – 43 million have hyperuricemia , 8 million with gout During gout flare, urate can](https://reader033.vdocuments.site/reader033/viewer/2022060410/5f105d1a7e708231d448be0c/html5/thumbnails/28.jpg)
Case # 3Case # 3
�� 57 y o with acute 57 y o with acute
onset of toe and onset of toe and
ankle painankle pain
�� HTN, DM IIHTN, DM II
�� No traumaNo trauma
�� Low grade feverLow grade fever
�� What do you What do you
order?order?
![Page 29: Appropriate Serologic Testing to Evaluate Rheumatic …Do not treat asymptomatic hyperuricemia – 43 million have hyperuricemia , 8 million with gout During gout flare, urate can](https://reader033.vdocuments.site/reader033/viewer/2022060410/5f105d1a7e708231d448be0c/html5/thumbnails/29.jpg)
Mono/Mono/pauciarthritispauciarthritis
�� The Eye of the NeedleThe Eye of the Needle–– Rule out Rule out infection,trauma,hemarthrosisinfection,trauma,hemarthrosis
–– Confirm crystalsConfirm crystals�� MSU MSU –– goutgout
�� CPPD CPPD –– pseudogoutpseudogout
�� Apatite Apatite –– pseudogoutpseudogout, crystals not , crystals not birefringentbirefringent, not , not seen on polarizing microscopeseen on polarizing microscope
�� LabsLabs–– Uric acidUric acid
–– Inflammatory markersInflammatory markers
–– Coagulation panelCoagulation panel
![Page 30: Appropriate Serologic Testing to Evaluate Rheumatic …Do not treat asymptomatic hyperuricemia – 43 million have hyperuricemia , 8 million with gout During gout flare, urate can](https://reader033.vdocuments.site/reader033/viewer/2022060410/5f105d1a7e708231d448be0c/html5/thumbnails/30.jpg)
Serum uric acidSerum uric acid
��Males postMales post--puberty mean puberty mean urateurate 5.25.2
––ULN ~ 7mg/dlULN ~ 7mg/dl
––Men with Men with sUAsUA>9.0, 22% develop gout >9.0, 22% develop gout
after 5 yearsafter 5 years
�� PrePre--menopausal women mean 4.0menopausal women mean 4.0
–– Estrogens have a Estrogens have a uricosuricuricosuric effecteffect
�� PostPost--menopausal mean 4.7menopausal mean 4.7
––ULN ~ 6mg/dlULN ~ 6mg/dl
![Page 31: Appropriate Serologic Testing to Evaluate Rheumatic …Do not treat asymptomatic hyperuricemia – 43 million have hyperuricemia , 8 million with gout During gout flare, urate can](https://reader033.vdocuments.site/reader033/viewer/2022060410/5f105d1a7e708231d448be0c/html5/thumbnails/31.jpg)
Uric acidUric acid
�� Do not treat asymptomatic Do not treat asymptomatic hyperuricemiahyperuricemia–– 43 million have 43 million have hyperuricemiahyperuricemia, 8 million with gout, 8 million with gout
�� During gout flare, During gout flare, urateurate can be high, normal or can be high, normal or lowlow–– Best time to check baseline is 2 weeks after flare has Best time to check baseline is 2 weeks after flare has resolvedresolved
�� 90% gout patients are 90% gout patients are underexcretorsunderexcretors–– 24 hour urine for 24 hour urine for urateurate and Cr excretion on regular and Cr excretion on regular purinepurine dietdiet
–– UrateUrate >800mg, overproducer; <800mg is >800mg, overproducer; <800mg is underexcretorunderexcretor
–– Spot urine Spot urine urateurate not nearly as accuratenot nearly as accurate
![Page 32: Appropriate Serologic Testing to Evaluate Rheumatic …Do not treat asymptomatic hyperuricemia – 43 million have hyperuricemia , 8 million with gout During gout flare, urate can](https://reader033.vdocuments.site/reader033/viewer/2022060410/5f105d1a7e708231d448be0c/html5/thumbnails/32.jpg)
What if crystal exam is negative?What if crystal exam is negative?
��Repeat synovial fluid analysis Repeat synovial fluid analysis
improves sensitivityimproves sensitivity
�� EULAR does allow for presumptive EULAR does allow for presumptive
diagnosisdiagnosis
![Page 33: Appropriate Serologic Testing to Evaluate Rheumatic …Do not treat asymptomatic hyperuricemia – 43 million have hyperuricemia , 8 million with gout During gout flare, urate can](https://reader033.vdocuments.site/reader033/viewer/2022060410/5f105d1a7e708231d448be0c/html5/thumbnails/33.jpg)
Case # 4Case # 4
�� 52 y o female 52 y o female
complains of complains of
fatigue, trouble fatigue, trouble
climbing stairs, climbing stairs,
getting dressed but getting dressed but
no painno pain
�� Rash noted on Rash noted on
exam, strength 4/5 exam, strength 4/5
proximal musclesproximal muscles
![Page 34: Appropriate Serologic Testing to Evaluate Rheumatic …Do not treat asymptomatic hyperuricemia – 43 million have hyperuricemia , 8 million with gout During gout flare, urate can](https://reader033.vdocuments.site/reader033/viewer/2022060410/5f105d1a7e708231d448be0c/html5/thumbnails/34.jpg)
Idiopathic Inflammatory Idiopathic Inflammatory MyopathiesMyopathiesPolymyositis/DermatomyositisPolymyositis/Dermatomyositis
�� Nonspecific abnormalitiesNonspecific abnormalities
–– CK, CK, aldolasealdolase, AST, ALT, ESR, LDH, AST, ALT, ESR, LDH
–– Elevations of CK can be due to macroElevations of CK can be due to macro--CKCK
�� MyositisMyositis--associated and associated and myositismyositis--specific specific
autoantibodiesautoantibodies
�� Mimics/Mimics/DDxDDx
–– TSH, serum and urine TSH, serum and urine myoglobinmyoglobin, , VitVit D, drug D, drug
screen, HIVscreen, HIV
–– In In myositismyositis vsvs rhabdomyolysisrhabdomyolysis, CK rarely , CK rarely
above 50 x ULNabove 50 x ULN
![Page 35: Appropriate Serologic Testing to Evaluate Rheumatic …Do not treat asymptomatic hyperuricemia – 43 million have hyperuricemia , 8 million with gout During gout flare, urate can](https://reader033.vdocuments.site/reader033/viewer/2022060410/5f105d1a7e708231d448be0c/html5/thumbnails/35.jpg)
MyositisMyositis--associated absassociated abs
��ANA (50ANA (50--80%)80%)
��AntiAnti--RNP RNP abab (MCTD/OCTD)(MCTD/OCTD)
��AntiAnti--PMPM--SclScl abab (PM(PM--scleroderma)scleroderma)
��AntiAnti--Ku Ku abab (PM(PM--scleroderma)scleroderma)
![Page 36: Appropriate Serologic Testing to Evaluate Rheumatic …Do not treat asymptomatic hyperuricemia – 43 million have hyperuricemia , 8 million with gout During gout flare, urate can](https://reader033.vdocuments.site/reader033/viewer/2022060410/5f105d1a7e708231d448be0c/html5/thumbnails/36.jpg)
MyositisMyositis--specific absspecific abs
ClassicClassic
DMDM
55--10%10%AntiAnti--MiMi--22
Severe Severe
ResistantResistant
PMPM
<5%<5%AntiAnti--SRPSRP
AntisynthetaseAntisynthetase
SyndromeSyndrome
2020--50%50%AntisynthetaseAntisynthetase
e.g. antie.g. anti--JoJo--11
Clinical Clinical
AssociationAssociation
Prevalence Prevalence
DM/PMDM/PM
Autoantibody Autoantibody
![Page 37: Appropriate Serologic Testing to Evaluate Rheumatic …Do not treat asymptomatic hyperuricemia – 43 million have hyperuricemia , 8 million with gout During gout flare, urate can](https://reader033.vdocuments.site/reader033/viewer/2022060410/5f105d1a7e708231d448be0c/html5/thumbnails/37.jpg)
Objective #2Objective #2
��Recognize the serologic associations Recognize the serologic associations
of rheumatic diseasesof rheumatic diseases
![Page 38: Appropriate Serologic Testing to Evaluate Rheumatic …Do not treat asymptomatic hyperuricemia – 43 million have hyperuricemia , 8 million with gout During gout flare, urate can](https://reader033.vdocuments.site/reader033/viewer/2022060410/5f105d1a7e708231d448be0c/html5/thumbnails/38.jpg)
Case # 5Case # 5
�� 34 34 yy--oo presents presents
with rash after with rash after
cruise to Caribbeancruise to Caribbean
�� AcheyAchey joints, low joints, low
grade fevers, grade fevers,
fatigue, weight lossfatigue, weight loss
�� What do you What do you
order?order?
![Page 39: Appropriate Serologic Testing to Evaluate Rheumatic …Do not treat asymptomatic hyperuricemia – 43 million have hyperuricemia , 8 million with gout During gout flare, urate can](https://reader033.vdocuments.site/reader033/viewer/2022060410/5f105d1a7e708231d448be0c/html5/thumbnails/39.jpg)
ANAANA
��ANA panelANA panel
��ANA 95ANA 95--100% sensitive in SLE, but 100% sensitive in SLE, but
far less specificfar less specific
��AutoantibodiesAutoantibodies are hallmark of SLE: are hallmark of SLE:
some diagnostic criteria, some useful some diagnostic criteria, some useful
for prognosis/markers of disease for prognosis/markers of disease
activityactivity
![Page 40: Appropriate Serologic Testing to Evaluate Rheumatic …Do not treat asymptomatic hyperuricemia – 43 million have hyperuricemia , 8 million with gout During gout flare, urate can](https://reader033.vdocuments.site/reader033/viewer/2022060410/5f105d1a7e708231d448be0c/html5/thumbnails/40.jpg)
ANAANA
�� Presence of a high titer (>1:640) Presence of a high titer (>1:640) increases suspicion of an autoimmune increases suspicion of an autoimmune disease, but is not diagnosticdisease, but is not diagnostic
�� Titers can fluctuateTiters can fluctuate–– This is not reflective of disease activity, and it This is not reflective of disease activity, and it
is not indicated to follow seriallyis not indicated to follow serially
–– Titers that disappear are less clinically Titers that disappear are less clinically significantsignificant
�� Low titers common in general population Low titers common in general population and in firstand in first--degree relatives of patients degree relatives of patients with ANAwith ANA--associated rheumatic diseaseassociated rheumatic disease
![Page 41: Appropriate Serologic Testing to Evaluate Rheumatic …Do not treat asymptomatic hyperuricemia – 43 million have hyperuricemia , 8 million with gout During gout flare, urate can](https://reader033.vdocuments.site/reader033/viewer/2022060410/5f105d1a7e708231d448be0c/html5/thumbnails/41.jpg)
Sensitivity of ANA in Rheumatic Sensitivity of ANA in Rheumatic
DiseasesDiseases
��SLE (95SLE (95--100%)100%)
��Scleroderma (60Scleroderma (60--80%)80%)
��MCTD (100%)MCTD (100%)
��RA (50%)RA (50%)
��SjogrenSjogren’’ss (40(40--70%)70%)
��Discoid lupus (15%)Discoid lupus (15%)
��DrugDrug--induced lupus (100%)induced lupus (100%)
![Page 42: Appropriate Serologic Testing to Evaluate Rheumatic …Do not treat asymptomatic hyperuricemia – 43 million have hyperuricemia , 8 million with gout During gout flare, urate can](https://reader033.vdocuments.site/reader033/viewer/2022060410/5f105d1a7e708231d448be0c/html5/thumbnails/42.jpg)
NonNon--rheumatic diseases rheumatic diseases
associated with +ANAassociated with +ANA
��HashimotoHashimoto’’s s thyroiditisthyroiditis (46% (46%
sensitivity)sensitivity)
��GravesGraves’’ disease (50%)disease (50%)
��Autoimmune hepatitis (100%)Autoimmune hepatitis (100%)
�� Primary autoimmune Primary autoimmune cholangitischolangitis
(100%)(100%)
�� Primary pulmonary hypertension Primary pulmonary hypertension
(40%)(40%)
![Page 43: Appropriate Serologic Testing to Evaluate Rheumatic …Do not treat asymptomatic hyperuricemia – 43 million have hyperuricemia , 8 million with gout During gout flare, urate can](https://reader033.vdocuments.site/reader033/viewer/2022060410/5f105d1a7e708231d448be0c/html5/thumbnails/43.jpg)
SLE and Autoantibody SubsetsSLE and Autoantibody Subsets
ENA 1ENA 1
��SmithSmith
–– A diagnostic criteria and highly specificA diagnostic criteria and highly specific
–– Sensitivity 20Sensitivity 20--30%30%
��RNPRNP
––Defining feature of MCTDDefining feature of MCTD
![Page 44: Appropriate Serologic Testing to Evaluate Rheumatic …Do not treat asymptomatic hyperuricemia – 43 million have hyperuricemia , 8 million with gout During gout flare, urate can](https://reader033.vdocuments.site/reader033/viewer/2022060410/5f105d1a7e708231d448be0c/html5/thumbnails/44.jpg)
Autoantibody SubsetsAutoantibody Subsets
ENA 2ENA 2�� Ro/SSARo/SSA
–– Part of diagnostic criteria for Part of diagnostic criteria for SjogrenSjogren’’ss
�� High titer associated with High titer associated with extraglandularextraglandular featuresfeatures
–– ANAANA--negative SLEnegative SLE
–– Neonatal lupus and CHBNeonatal lupus and CHB
�� Mother antiMother anti--Ro+, risk of fetus with CHB 2Ro+, risk of fetus with CHB 2--5%5%
–– SubacuteSubacute cutaneouscutaneous lupus, lupus, cutaneouscutaneous vasculitisvasculitis, ILD and , ILD and photosensitive dermatitis (normal population)photosensitive dermatitis (normal population)
�� La/SSBLa/SSB–– Part of diagnostic criteria for Part of diagnostic criteria for SjogrenSjogren’’ss
–– 15% of SLE patients but rare in other systemic 15% of SLE patients but rare in other systemic rheumatic diseasesrheumatic diseases
–– Isolated SSB seen in some patients with PBC and AIHIsolated SSB seen in some patients with PBC and AIH
![Page 45: Appropriate Serologic Testing to Evaluate Rheumatic …Do not treat asymptomatic hyperuricemia – 43 million have hyperuricemia , 8 million with gout During gout flare, urate can](https://reader033.vdocuments.site/reader033/viewer/2022060410/5f105d1a7e708231d448be0c/html5/thumbnails/45.jpg)
SLE and Autoantibody SubsetsSLE and Autoantibody Subsets
�� dsDNAdsDNA
–– A diagnostic criteriaA diagnostic criteria
––Highly specific ~95%Highly specific ~95%
��Sensitivity ~80%Sensitivity ~80%
––Marker of disease activity (renal) Marker of disease activity (renal)
especially with low complement; especially with low complement;
elevations often precede flares elevations often precede flares
![Page 46: Appropriate Serologic Testing to Evaluate Rheumatic …Do not treat asymptomatic hyperuricemia – 43 million have hyperuricemia , 8 million with gout During gout flare, urate can](https://reader033.vdocuments.site/reader033/viewer/2022060410/5f105d1a7e708231d448be0c/html5/thumbnails/46.jpg)
AutoantibodiesAutoantibodies in Systemic in Systemic
LupusLupus
�� Department of Department of Defense Serum Defense Serum Repository; Repository; evaluated 130 evaluated 130 controls prior to controls prior to SLE diagnosisSLE diagnosis
�� 115/130 115/130 (88%)present (88%)present before diagnosis before diagnosis (up to 9.4 years, (up to 9.4 years, mean 3.3)mean 3.3)
�� ANA 78%ANA 78%
�� dsDNAdsDNA 55%55%
�� Progression of Progression of
development:development:
–– ANA, Ro/La, APL absANA, Ro/La, APL abs
–– Later Later dsDNAdsDNA then then
SmSm/RNP/RNP
Arbuckle, et al. (2003). Development of autoantibodies before the clinical onset of systemic lupus erythematousus. NEJM, 34 1526-1533.
![Page 47: Appropriate Serologic Testing to Evaluate Rheumatic …Do not treat asymptomatic hyperuricemia – 43 million have hyperuricemia , 8 million with gout During gout flare, urate can](https://reader033.vdocuments.site/reader033/viewer/2022060410/5f105d1a7e708231d448be0c/html5/thumbnails/47.jpg)
![Page 48: Appropriate Serologic Testing to Evaluate Rheumatic …Do not treat asymptomatic hyperuricemia – 43 million have hyperuricemia , 8 million with gout During gout flare, urate can](https://reader033.vdocuments.site/reader033/viewer/2022060410/5f105d1a7e708231d448be0c/html5/thumbnails/48.jpg)
AntiAnti--CentromereCentromere antibody (ACA)antibody (ACA)
��Highly specific for scleroderma ~98%Highly specific for scleroderma ~98%
�� Found almost exclusively in limited Found almost exclusively in limited systemic sclerosis (CREST) (57%)systemic sclerosis (CREST) (57%)––CCalcinosisalcinosis
––RRaynaudsaynauds
––EEsophageal sophageal dysmotilitydysmotility
––SSclerodatylyclerodatyly
––TTelangiectasiaselangiectasias
![Page 49: Appropriate Serologic Testing to Evaluate Rheumatic …Do not treat asymptomatic hyperuricemia – 43 million have hyperuricemia , 8 million with gout During gout flare, urate can](https://reader033.vdocuments.site/reader033/viewer/2022060410/5f105d1a7e708231d448be0c/html5/thumbnails/49.jpg)
AntiAnti--SCLSCL--70 antibodies70 antibodies
(topoisomerase(topoisomerase--1)1)
��Highly specific for scleroderma ~95%Highly specific for scleroderma ~95%
�� Tightly affiliated with diffuse Tightly affiliated with diffuse
systemic sclerosissystemic sclerosis
–– Associated with high risk of ILDAssociated with high risk of ILD
![Page 50: Appropriate Serologic Testing to Evaluate Rheumatic …Do not treat asymptomatic hyperuricemia – 43 million have hyperuricemia , 8 million with gout During gout flare, urate can](https://reader033.vdocuments.site/reader033/viewer/2022060410/5f105d1a7e708231d448be0c/html5/thumbnails/50.jpg)
AntiAnti--histonehistone antibodiesantibodies
�� Present in 95% of DIL (drugPresent in 95% of DIL (drug--induced induced
lupus) patientslupus) patients
�� ProcainamideProcainamide, , HydralazineHydralazine, , IsoniazidIsoniazid
��Also present in up to 80% of SLE ptsAlso present in up to 80% of SLE pts
![Page 51: Appropriate Serologic Testing to Evaluate Rheumatic …Do not treat asymptomatic hyperuricemia – 43 million have hyperuricemia , 8 million with gout During gout flare, urate can](https://reader033.vdocuments.site/reader033/viewer/2022060410/5f105d1a7e708231d448be0c/html5/thumbnails/51.jpg)
Positive ANAPositive ANA
High probability of autoimmunerheumatic disease
Identify specificantigen
Search forevidence of other disease or organinvolvement
Ancillary tests e.g.Complement,
Coombs
![Page 52: Appropriate Serologic Testing to Evaluate Rheumatic …Do not treat asymptomatic hyperuricemia – 43 million have hyperuricemia , 8 million with gout During gout flare, urate can](https://reader033.vdocuments.site/reader033/viewer/2022060410/5f105d1a7e708231d448be0c/html5/thumbnails/52.jpg)
Positive ANAPositive ANA
Low probabilityof autoimmune
rheumatic disease
Low titer or transient titer:Reassure patient
High titer orpersistent titer:
Search foralternative dx
High titer or persistent titer:Follow patient
![Page 53: Appropriate Serologic Testing to Evaluate Rheumatic …Do not treat asymptomatic hyperuricemia – 43 million have hyperuricemia , 8 million with gout During gout flare, urate can](https://reader033.vdocuments.site/reader033/viewer/2022060410/5f105d1a7e708231d448be0c/html5/thumbnails/53.jpg)
ANAANA
��A hallmark of rheumatic diseaseA hallmark of rheumatic disease
�� For diagnosis of SLE, sensitivity of For diagnosis of SLE, sensitivity of
~95% and specificity of 57%~95% and specificity of 57%
�� Primary utility diagnostically is the Primary utility diagnostically is the
NPV for SLE if ANA is negativeNPV for SLE if ANA is negative
��May support the diagnosis of other May support the diagnosis of other
rheumatic disease but does not rule rheumatic disease but does not rule
in or out other specific diseasesin or out other specific diseases
![Page 54: Appropriate Serologic Testing to Evaluate Rheumatic …Do not treat asymptomatic hyperuricemia – 43 million have hyperuricemia , 8 million with gout During gout flare, urate can](https://reader033.vdocuments.site/reader033/viewer/2022060410/5f105d1a7e708231d448be0c/html5/thumbnails/54.jpg)
Case # 6Case # 6
�� 60 60 yoyo male hospitalized with male hospitalized with
pneumonia,dehydrationpneumonia,dehydration/nausea from /nausea from
oral antibioticsoral antibiotics
��Cr 1.1 Cr 1.1 HbHb 12 12 pltplt 120 WBC 12 120 WBC 12
cANCAcANCA 1:1601:160
��Does this patient have Does this patient have
GranulomatosisGranulomatosis with with PolyangiiitisPolyangiiitis
((WegenersWegeners)?)?
![Page 55: Appropriate Serologic Testing to Evaluate Rheumatic …Do not treat asymptomatic hyperuricemia – 43 million have hyperuricemia , 8 million with gout During gout flare, urate can](https://reader033.vdocuments.site/reader033/viewer/2022060410/5f105d1a7e708231d448be0c/html5/thumbnails/55.jpg)
AntiAnti--NeutrophilNeutrophil CytoplasmicCytoplasmic
Antibody (ANCA)Antibody (ANCA)�� Two patterns:Two patterns:
–– cc--ANCA = diffuse granular staining throughout ANCA = diffuse granular staining throughout cytoplasmcytoplasm�� Antigen recognized is usually a PMN granule Antigen recognized is usually a PMN granule constituent proteinaseconstituent proteinase--3 (Pr3 (Pr--3)3)
�� Found primarily in Found primarily in GranulomatosisGranulomatosis with with PolyangiitisPolyangiitis((WegenersWegeners))
–– pp--ANCA = ANCA = perinuclearperinuclear staining of cytoplasmstaining of cytoplasm�� Many antigens (Many antigens (elastaseelastase, , lysozymelysozyme, , lactoferrinlactoferrin) ) but but
most common and important is PMN granule most common and important is PMN granule constitutentconstitutent myeloperoxidasemyeloperoxidase (MPO)(MPO)
�� NonNon--MPO MPO pANCAspANCAs seen with nonseen with non--rheumatic diseases rheumatic diseases (IBD, HIV, drug(IBD, HIV, drug--induced ANCA e.g.); recognized as induced ANCA e.g.); recognized as atypical atypical ANCAsANCAs
![Page 56: Appropriate Serologic Testing to Evaluate Rheumatic …Do not treat asymptomatic hyperuricemia – 43 million have hyperuricemia , 8 million with gout During gout flare, urate can](https://reader033.vdocuments.site/reader033/viewer/2022060410/5f105d1a7e708231d448be0c/html5/thumbnails/56.jpg)
Sensitivity of cSensitivity of c--ANCA for ANCA for
GranulomatosisGranulomatosis with with PolyangiitisPolyangiitis
35%35%65%65%Limited WGLimited WG
65%65%95%95%Classic, multiClassic, multi--
system WGsystem WG
InactiveInactive
(treated)(treated)
DiseaseDisease
Active Active
DiseaseDisease
![Page 57: Appropriate Serologic Testing to Evaluate Rheumatic …Do not treat asymptomatic hyperuricemia – 43 million have hyperuricemia , 8 million with gout During gout flare, urate can](https://reader033.vdocuments.site/reader033/viewer/2022060410/5f105d1a7e708231d448be0c/html5/thumbnails/57.jpg)
Case # 6Case # 6
��No history renal No history renal dzdz, sinusitis, , sinusitis,
hemoptysishemoptysis
��No prior med use, only No prior med use, only LevaquinLevaquin
��CXR RLL infiltrate, sinus films CXR RLL infiltrate, sinus films
negativenegative
�� Patient is unlikely to have Patient is unlikely to have
GranulomatosisGranulomatosis with with PolyangiitisPolyangiitis
because of because of low PPV of this testlow PPV of this test
![Page 58: Appropriate Serologic Testing to Evaluate Rheumatic …Do not treat asymptomatic hyperuricemia – 43 million have hyperuricemia , 8 million with gout During gout flare, urate can](https://reader033.vdocuments.site/reader033/viewer/2022060410/5f105d1a7e708231d448be0c/html5/thumbnails/58.jpg)
ANCAsANCAs
�� The predictive value depends upon The predictive value depends upon
clinical presentationclinical presentation
��Negative ANCA does not exclude the Negative ANCA does not exclude the
diagnosis of AAVdiagnosis of AAV
![Page 59: Appropriate Serologic Testing to Evaluate Rheumatic …Do not treat asymptomatic hyperuricemia – 43 million have hyperuricemia , 8 million with gout During gout flare, urate can](https://reader033.vdocuments.site/reader033/viewer/2022060410/5f105d1a7e708231d448be0c/html5/thumbnails/59.jpg)
Objective 3Objective 3
��Apply sensitivity, specificity, Apply sensitivity, specificity,
likelihood ratio and positive likelihood ratio and positive
predictive value to laboratory testing predictive value to laboratory testing
in clinical practicein clinical practice
![Page 60: Appropriate Serologic Testing to Evaluate Rheumatic …Do not treat asymptomatic hyperuricemia – 43 million have hyperuricemia , 8 million with gout During gout flare, urate can](https://reader033.vdocuments.site/reader033/viewer/2022060410/5f105d1a7e708231d448be0c/html5/thumbnails/60.jpg)
Sensitivity and SpecificitySensitivity and Specificity
�� Sensitivity = True Sensitivity = True
Positives/Total with Positives/Total with
DiseaseDisease
�� TP/(TP+FN)TP/(TP+FN)
�� Specificity = True Specificity = True
Negatives/Total Negatives/Total
without Diseasewithout Disease
�� TN/(TN+FP)TN/(TN+FP)
True True
Neg.Neg.
(TN)(TN)
False False
PositivePositive
(FP)(FP)
Subject Subject
W/oW/o
DxDx
False False
Neg.Neg.
(FN)(FN)
TrueTrue
PositivePositive
(TP)(TP)
SubjectSubject
With With
DxDx
NegativeNegative
Test Test
ResultResult
Positive Positive
Test Test
ResultResult
![Page 61: Appropriate Serologic Testing to Evaluate Rheumatic …Do not treat asymptomatic hyperuricemia – 43 million have hyperuricemia , 8 million with gout During gout flare, urate can](https://reader033.vdocuments.site/reader033/viewer/2022060410/5f105d1a7e708231d448be0c/html5/thumbnails/61.jpg)
Prevalence of SLE in USAPrevalence of SLE in USA
�� 2008 reported to be 100 per 100,000 2008 reported to be 100 per 100,000
adult womenadult women
��Prevalence of 0.1%Prevalence of 0.1%
��SLE in men 1/10SLE in men 1/10thth
��Does a +ANA=SLE?Does a +ANA=SLE?
![Page 62: Appropriate Serologic Testing to Evaluate Rheumatic …Do not treat asymptomatic hyperuricemia – 43 million have hyperuricemia , 8 million with gout During gout flare, urate can](https://reader033.vdocuments.site/reader033/viewer/2022060410/5f105d1a7e708231d448be0c/html5/thumbnails/62.jpg)
Does +ANA = SLE? NODoes +ANA = SLE? NO
1,000,01,000,0
0000999,000999,00010001000
~949,000~949,0005050ANA ANA --
~50,000~50,000950950ANA +ANA +
SLESLE
NoNo
SLESLE
YesYes
If ANA 95% sensitive and 95% specific
+ANA post-test probability = 950/50,000 = 1/50 =2%
Pretest probability in random population = prevalence = 0.1%
![Page 63: Appropriate Serologic Testing to Evaluate Rheumatic …Do not treat asymptomatic hyperuricemia – 43 million have hyperuricemia , 8 million with gout During gout flare, urate can](https://reader033.vdocuments.site/reader033/viewer/2022060410/5f105d1a7e708231d448be0c/html5/thumbnails/63.jpg)
What if ANA only 80% Specific?What if ANA only 80% Specific?
1,000,01,000,0
0000999,000999,00010001000
799,250799,250~799,200~799,2005050ANA ANA --
200,750200,750~199,800~199,800950950ANA +ANA +
Totals Totals SLESLE
NoNo
SLESLE
Yes Yes
+ANA post-test probability = 950/200,750 = 0.5%
ANA 95% sensitive and 80% specific
Pretest probability in random population = prevalence = 0.1%
![Page 64: Appropriate Serologic Testing to Evaluate Rheumatic …Do not treat asymptomatic hyperuricemia – 43 million have hyperuricemia , 8 million with gout During gout flare, urate can](https://reader033.vdocuments.site/reader033/viewer/2022060410/5f105d1a7e708231d448be0c/html5/thumbnails/64.jpg)
Likelihood RatioLikelihood Ratio
�� Positive LRPositive LR
–– True positive rate/True positive rate/
false positive ratefalse positive rate
–– TP/FPTP/FP
�� Negative LRNegative LR
–– False neg. rate/False neg. rate/
true neg. ratetrue neg. rate
–– FN/TNFN/TN
![Page 65: Appropriate Serologic Testing to Evaluate Rheumatic …Do not treat asymptomatic hyperuricemia – 43 million have hyperuricemia , 8 million with gout During gout flare, urate can](https://reader033.vdocuments.site/reader033/viewer/2022060410/5f105d1a7e708231d448be0c/html5/thumbnails/65.jpg)
Likelihood RatioLikelihood Ratio
�� Positive LRPositive LR–– Higher is betterHigher is better
–– LR+>5 considered good testLR+>5 considered good test
�� Negative LRNegative LR–– Lower is betterLower is better
–– LRLR--<0.2 considered good test<0.2 considered good test
�� LR+ or LRLR+ or LR-- close to 1.0: test not close to 1.0: test not predictivepredictive
�� LR multiplied by preLR multiplied by pre--test odds = posttest odds = post--test oddstest odds
![Page 66: Appropriate Serologic Testing to Evaluate Rheumatic …Do not treat asymptomatic hyperuricemia – 43 million have hyperuricemia , 8 million with gout During gout flare, urate can](https://reader033.vdocuments.site/reader033/viewer/2022060410/5f105d1a7e708231d448be0c/html5/thumbnails/66.jpg)
LR with Low PreLR with Low Pre--test Probabilitytest Probability
�� ANA 1:40 threshold, 95% sensitivity and ANA 1:40 threshold, 95% sensitivity and specificity for given labspecificity for given lab–– LR+ = 95%/5% = 19LR+ = 95%/5% = 19
–– LRLR-- =5%/95% = 0.053=5%/95% = 0.053
�� Patient with estimated prePatient with estimated pre--test probability test probability of SLE of 1% (0.01)of SLE of 1% (0.01)
�� If ANA negative at 1:40, then postIf ANA negative at 1:40, then post--test test odds ~ 0.01x0.05 = 0.0005 (1:2000)odds ~ 0.01x0.05 = 0.0005 (1:2000)
�� If ANA positive at 1:40, then postIf ANA positive at 1:40, then post--test test odds ~ 0.01x19 = 0.19 (1:5) odds still odds ~ 0.01x19 = 0.19 (1:5) odds still strongly against having SLEstrongly against having SLE
![Page 67: Appropriate Serologic Testing to Evaluate Rheumatic …Do not treat asymptomatic hyperuricemia – 43 million have hyperuricemia , 8 million with gout During gout flare, urate can](https://reader033.vdocuments.site/reader033/viewer/2022060410/5f105d1a7e708231d448be0c/html5/thumbnails/67.jpg)
LR with High PreLR with High Pre--test Probabilitytest Probability
�� ANA 1:40 threshold, 95% sensitivity and ANA 1:40 threshold, 95% sensitivity and specificity for given labspecificity for given lab
–– LR+ = 95%/5% = 19LR+ = 95%/5% = 19
–– LRLR-- =5%/95% = 0.053=5%/95% = 0.053
�� Patient with estimated prePatient with estimated pre--test probability test probability of SLE 50% (odds 1:1 or 1.0)of SLE 50% (odds 1:1 or 1.0)
�� If ANA is negative at 1:40, then postIf ANA is negative at 1:40, then post--test test odds ~ 1.0 x 0.5 =1:19odds ~ 1.0 x 0.5 =1:19
�� If ANA is positive at 1:40, then postIf ANA is positive at 1:40, then post--test test odds ~ 1 x 19 = odds ~ 1 x 19 = 1919 = 19:1 odds, strongly = 19:1 odds, strongly in favor of SLEin favor of SLE
![Page 68: Appropriate Serologic Testing to Evaluate Rheumatic …Do not treat asymptomatic hyperuricemia – 43 million have hyperuricemia , 8 million with gout During gout flare, urate can](https://reader033.vdocuments.site/reader033/viewer/2022060410/5f105d1a7e708231d448be0c/html5/thumbnails/68.jpg)
Positive Predictive ValuePositive Predictive Value
��How many of test positive patients How many of test positive patients
truly have the diseasetruly have the disease
––TP/TP+FPTP/TP+FP
��Dependent on the prevalence of the Dependent on the prevalence of the
disease in the population being disease in the population being
examined (pretest probability of examined (pretest probability of
disease)disease)
![Page 69: Appropriate Serologic Testing to Evaluate Rheumatic …Do not treat asymptomatic hyperuricemia – 43 million have hyperuricemia , 8 million with gout During gout flare, urate can](https://reader033.vdocuments.site/reader033/viewer/2022060410/5f105d1a7e708231d448be0c/html5/thumbnails/69.jpg)
Positive Predictive ValuePositive Predictive Value
PPV= (sensitivity)(prevalence)
(sensitivity)(prevalence) + (1-specificity)(1-prevalence)
![Page 70: Appropriate Serologic Testing to Evaluate Rheumatic …Do not treat asymptomatic hyperuricemia – 43 million have hyperuricemia , 8 million with gout During gout flare, urate can](https://reader033.vdocuments.site/reader033/viewer/2022060410/5f105d1a7e708231d448be0c/html5/thumbnails/70.jpg)
Case # 6 Case # 6
�� The PPV of cThe PPV of c--ANCA is low because:ANCA is low because:
–– cANCAcANCA specificity is only 25%specificity is only 25%
–– cANCAcANCA sensitivity is only 40%sensitivity is only 40%
–– Low Low prevalanceprevalance of diseaseof disease
–– The negative likelihood ratio is highThe negative likelihood ratio is high
![Page 71: Appropriate Serologic Testing to Evaluate Rheumatic …Do not treat asymptomatic hyperuricemia – 43 million have hyperuricemia , 8 million with gout During gout flare, urate can](https://reader033.vdocuments.site/reader033/viewer/2022060410/5f105d1a7e708231d448be0c/html5/thumbnails/71.jpg)
Case # 6Case # 6
��Does he have Does he have GranulomatosisGranulomatosis with with
PolyangiitisPolyangiitis??
��NONO
��WHY?WHY?
–– Low prevalence of diseaseLow prevalence of disease
–– 3 per 100,000 in US (0.00003%)3 per 100,000 in US (0.00003%)
![Page 72: Appropriate Serologic Testing to Evaluate Rheumatic …Do not treat asymptomatic hyperuricemia – 43 million have hyperuricemia , 8 million with gout During gout flare, urate can](https://reader033.vdocuments.site/reader033/viewer/2022060410/5f105d1a7e708231d448be0c/html5/thumbnails/72.jpg)
Conclusions Conclusions
�� Lab tests can be supportive of the Lab tests can be supportive of the
diagnosis and useful to monitor diagnosis and useful to monitor
disease activity, disease activity, but are rarely but are rarely
diagnosticdiagnostic
�� Lab test must be interpreted in the Lab test must be interpreted in the
context of clinical presentation, and context of clinical presentation, and
understanding of sensitivity, understanding of sensitivity,
specificity, prevalence of diseasespecificity, prevalence of disease
![Page 73: Appropriate Serologic Testing to Evaluate Rheumatic …Do not treat asymptomatic hyperuricemia – 43 million have hyperuricemia , 8 million with gout During gout flare, urate can](https://reader033.vdocuments.site/reader033/viewer/2022060410/5f105d1a7e708231d448be0c/html5/thumbnails/73.jpg)
Case # 1Case # 1
�� 28 28 yy--oo female, tired, female, tired, HAsHAs, hurts , hurts
alloverallover
��ANA 1:160ANA 1:160
��What does she have?What does she have?
�� FIBROMYALGIAFIBROMYALGIA
![Page 74: Appropriate Serologic Testing to Evaluate Rheumatic …Do not treat asymptomatic hyperuricemia – 43 million have hyperuricemia , 8 million with gout During gout flare, urate can](https://reader033.vdocuments.site/reader033/viewer/2022060410/5f105d1a7e708231d448be0c/html5/thumbnails/74.jpg)
References References
��ACR online Advanced Rheumatology ACR online Advanced Rheumatology
CourseCourse
�� Practical RheumatologyPractical Rheumatology. 3. 3rdrd edition, edition,
2004, pp 572004, pp 57--72.72.
��Rheumatology SecretsRheumatology Secrets. 2. 2ndnd edition, edition,
Sterling G West MD, editor. 2002, pp Sterling G West MD, editor. 2002, pp
5252--62.62.
![Page 75: Appropriate Serologic Testing to Evaluate Rheumatic …Do not treat asymptomatic hyperuricemia – 43 million have hyperuricemia , 8 million with gout During gout flare, urate can](https://reader033.vdocuments.site/reader033/viewer/2022060410/5f105d1a7e708231d448be0c/html5/thumbnails/75.jpg)
Clinical PearlsClinical Pearls
�� Upper limit of ESR for men age/2 but for Upper limit of ESR for men age/2 but for women (age + 10)/2women (age + 10)/2
�� High RF and CCP+ is highly specific for RA High RF and CCP+ is highly specific for RA and portends a worse prognosisand portends a worse prognosis
�� High RF and negative CCP: think High RF and negative CCP: think HepCHepC
�� The negative predictive value of an ANA is The negative predictive value of an ANA is high, but the PPV is lowhigh, but the PPV is low
�� Gout does not occur in premenopausal Gout does not occur in premenopausal womenwomen
�� DonDon’’t order a lab test unless it will change t order a lab test unless it will change your management planyour management plan